MSU collaborates to understand and target COVID-19 coronavirus host cell entry
With global cases of COVID-19 surpassing four million, researchers are continuing to learn more about the virus, and trying to find ways to treat it. The SARS-Cov-2 coronavirus that causes COVID-19 uses the angiotensin-converting enzyme 2 (ACE2) receptor to gain entry to host cells. At MSU, a collaboration has begun among the labs of Bruce Uhal, Yong-Hui Zheng, and the MSU Drug Discovery group to further understand the entry mechanism and to discover methods to block the virus and host cell interaction.